TY - JOUR AU - Mahajan, Manali Mangesh AU - Dudhgaonkar, Sujata AU - Deshmukh, Swapnil Narayan PY - 2017/01/20 Y2 - 2024/03/29 TI - Imprudent use of proton pump inhibitors in current practice JF - International Journal of Basic & Clinical Pharmacology JA - Int J Basic Clin Pharmacol VL - 4 IS - 1 SE - Letter to the Editor DO - UR - https://www.ijbcp.com/index.php/ijbcp/article/view/890 SP - 184-185 AB - <span>In a developing country like India, where over 500 branded formulations of PPI are available, probability of misuse and abuse increases exponentially. Although a safe and very effective class of pharmaceutical agent, PPIs should be used only when there is documented evidence of a GI disorder that cannot be treated with an H2-receptor antagonist, and where a PPI use is clinically justified. Increased clinician awareness on appropriate PPI prescription will lead to better patient outcome at lower cost.</span> ER -